Molecular Oncology Team at The Institute of Cancer Research, London


Professor Turner leads the Molecular Oncology Team at The Institute of Cancer Research, London. He has a laboratory in the Breast Cancer Now Toby Robins Research Centre – a world-leading facility comprising more than 70 cancer researchers – at the ICR.

He is also Chief Investigator of numerous clinical trials on personalised therapies for breast cancer, and a Consultant Medical Oncologist at The Royal Marsden NHS Foundation Trust, where he is also Head of the Ralph Lauren Centre for Breast Cancer Research.
The Academy of Medical Sciences recognises a global cohort of researchers each year with Fellowships for their exceptional achievements in medical science, which have advanced scientific progress and improved care and prospects for patients.

At the ICR, Professor Turner’s research involves analysing and validating new breast cancer therapies for different molecular subtypes of the disease. He helped pioneer and develop an innovative type of personalised blood test called a liquid biopsy that can predict when a patients’ breast cancer will return and spread.

Prof. Turner delivered the prestigious Pezcoller Foundation – EACR Translational Cancer Researcher Award Lecture at the EACR Annual Congress (Seville, 20-23 June 2022) and a lecture for CIBIO researchers, University of Trento (10 November 2022), with the title: Treatment strategies to tackle breast cancer heterogeneity.

Dr. Turner's Lecture

Prof. Nicholas Turner, winner of the 2022 Pezcoller Foundation- EACR Translational Cancer Researcher Award
unchecked checked